Owens & Minor names interim chairman and CEO

The leadership shakeup comes against the backdrop of consistently disappointing earnings that have seen the company's shares shed 75% of their value under CEO P. Cody Phipps.

By Susan Kelly • Nov. 9, 2018

Stryker closes $1.4B K2M acquisition

The medical device giant says the deal will augment its own spine and neurotechnology offerings.

By David Lim • Nov. 9, 2018

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Monteris modifies brain ablation device to counter safety risk

FDA cleared a new model that features a fiber optic probe designed to stop the original heating problem.

By Nick Paul Taylor • Nov. 9, 2018

Premier to acquire software company Stanson Health for $51.5M

Software-as-a-service provider Stanson's product pipeline includes a tool to give prior authorizations in near real time.

By Meg Bryant • Nov. 8, 2018

Rising Cordis costs drag on Cardinal Health profits

Increased expenditures at the troubled medical device unit stifled profitability.

By Nick Paul Taylor • Nov. 8, 2018

BD posts long-awaited clinical data on Lutonix balloon in CLI

If the approval and commercialization go to plan, BD thinks the below-the-knee opportunity is worth about $250 million a year.

By Nick Paul Taylor • Nov. 8, 2018

Shoulder device sales power Wright to beat-and-raise Q3

Strong growth emboldened the company to raise its outlook for the second successive quarter. Jefferies analysts wrote there is "no reason we can see to suggest Wright can't maintain double-digit underlying sales growth."

By Nick Paul Taylor • Nov. 8, 2018

Long-term data backs Medtronic drug-coated balloon for PAD

Five-year study data on the company's Admiral device to treat peripheral artery disease showed it continued to outperform standard angioplasty.

By Susan Kelly • Nov. 7, 2018

Fresh off of strong quarter, ResMed buys MatrixCare

The sleep apnea company is betting the acquisition will augment its existing software-as-a-service offerings such as Brightree and HEALTHCAREfirst.

By David Lim • Nov. 6, 2018

Becton Dickinson Q4 revenue up, some Wall Street misses

The device company aggressively remade itself in recent years to focus on higher-growth areas within the medical technology sector.

By Susan Kelly • Nov. 6, 2018

Abbott, J&J take part in FDA's NEST real world evidence pilot

The test cases will assess the role of RWE in proactive post-market surveillance, the evaluation of ablation devices and other activities across the medical device lifecycle.

By Nick Paul Taylor • Nov. 6, 2018

FDA approves 2 devices to aid in thyroid surgery

The products sold by Fluoptics and AiBiomed are designed to help surgeons locate parathyroid tissue or glands, which can be difficult to see during a procedure.

By Susan Kelly • Nov. 5, 2018

FDA extends time to comply on unique device identification

The agency said it is extending the compliance date for Class I and unclassified devices in response to industry concerns that reworking devices in inventory would be a costly burden.

By Susan Kelly • Nov. 5, 2018

Gap between perception, reality of connected medical device security, survey finds

Nearly two-thirds of health IT professionals trust traditional security measures like firewalls to protect connected medical devices from cyber attack, according to a new Zingbox survey, but that trust may be misplaced.

By Meg Bryant • Nov. 2, 2018

Midterms 2018: Key health ballot votes in the states

It's not just Congress up for grabs in Tuesday's midterm elections. From Medicaid expansion to dialysis treatments to nurse staffing ratios, here's a snapshot of key votes, the odds and what they could mean for the industry.

By David Lim , Tony Abraham , Rebecca Pifer , Samantha Liss • Nov. 2, 2018

FDA deficient on device cybersecurity readiness, watchdog says

The inspector general called the agency's postmarketing efforts to police cyber threats to medical devices insufficient. The FDA said the report paints "an incomplete and inadequate" picture of the agency's oversight.

By Susan Kelly • Nov. 2, 2018

CMS finalizes DME bidding program overhaul despite cost

Administrator Seema Verma said the final rule will increase patient access to medical products, but an August GAO report found beneficiaries are able to get needed items under the current paradigm.

By David Lim • Nov. 2, 2018

Patient deaths following Getinge device shutdowns prompt FDA warning

The agency has reports of three patient deaths following intra-aortic balloon pump malfunctions.

By Nick Paul Taylor • Nov. 2, 2018

Zimmer gets FDA nod for knee implant as portfolio strategy advances

Clearance coincided with first use of the device maker's knee surgery robot. The CEO has been vague about how it will differentiate its knee and spine devices from rival products, such as those sold by Mazor Robotics and Stryker.

By Nick Paul Taylor • Nov. 1, 2018

Moody's boosts growth forecast for US medical device industry

The ramped up prediction comes in response to strong sales of relatively new, high-margin products at companies such as Edwards Lifesciences and Medtronic.

By Nick Paul Taylor • Nov. 1, 2018

NuVasive CEO says spine industry poised to consolidate

The spinal device maker said it is moving from belt-tightening to investment mode to take advantage of improving market conditions.

By Susan Kelly • Oct. 31, 2018

Baxter posts 'frankly disappointing' sales as hurricane aftereffects linger

"It is now becoming clear that the market dynamics have fundamentally shifted, at least in the near- to mid-term," Baxter CEO José Almeida said on the quarterly conference call with investors.

By Nick Paul Taylor • Oct. 31, 2018

Baxter earns CE mark for new renal replacement system

Launch of the PrisMax device builds on the company's Prismaflex technology for filtering the blood of critically ill patients, and is a key event for the company's acute therapies business.

By Susan Kelly • Oct. 30, 2018

Genentech releases more data on refillable eye implant

Study results showed that vision and anatomical outcomes in wet AMD patients who received the device, and dosed every six months or longer, were comparable to ranibizumab dosed every four weeks.

By Susan Kelly • Oct. 30, 2018

Leerink predicts Inspire to clear coverage blockade, quickly grow sleep apnea sales

The upbeat estimates assume another major insurer will cover the implant in the next 18 months.

By Nick Paul Taylor • Oct. 30, 2018